Is ZEPP or MDXH more profitable?

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Zepp Health's return on equity. Company Net Margins Return on Equity Return on Assets Zepp Health -14.70% -15.64% -6.03% MDxHealth -29.90% N/A -22.51%

Is PIII or MDXH more profitable?

P3 Health Partners has a net margin of -8.57% compared to MDxHealth's net margin of -29.90%. Company Net Margins Return on Equity Return on Assets P3 Health Partners -8.57% N/A -19.99% MDxHealth -29.90% N/A -22.51%

Does the media refer more to PIII or MDXH?

In the previous week, MDxHealth had 4 more articles in the media than P3 Health Partners. MarketBeat recorded 6 mentions for MDxHealth and 2 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 0.63 beat MDxHealth's score of 0.57 indicating that P3 Health Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MDxHealth 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor OM or MDXH?

In the previous week, MDxHealth had 2 more articles in the media than Outset Medical. MarketBeat recorded 6 mentions for MDxHealth and 4 mentions for Outset Medical. Outset Medical's average media sentiment score of 1.34 beat MDxHealth's score of 0.57 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MDxHealth 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, NYXH or MDXH?

MDxHealth has higher revenue and earnings than Nyxoah. MDxHealth is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nyxoah $15.33M 3.54 -$101.92M -$2.48 N/A MDxHealth $110.97M 0.18 -$33.52M -$0.65 N/A

Is NYXH or MDXH more profitable?

MDxHealth has a net margin of -29.90% compared to Nyxoah's net margin of -543.21%. MDxHealth's return on equity of 0.00% beat Nyxoah's return on equity. Company Net Margins Return on Equity Return on Assets Nyxoah -543.21% -163.73% -80.24% MDxHealth -29.90% N/A -22.51%

Which has better valuation & earnings, LUNG or MDXH?

MDxHealth has higher revenue and earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pulmonx $88.55M 0.56 -$54M -$1.30 N/A MDxHealth $110.97M 0.18 -$33.52M -$0.65 N/A

Is LUNG or MDXH more profitable?

MDxHealth has a net margin of -29.90% compared to Pulmonx's net margin of -60.09%. MDxHealth's return on equity of 0.00% beat Pulmonx's return on equity. Company Net Margins Return on Equity Return on Assets Pulmonx -60.09% -92.94% -39.80% MDxHealth -29.90% N/A -22.51%

Does the media favor LUNG or MDXH?

In the previous week, MDxHealth had 3 more articles in the media than Pulmonx. MarketBeat recorded 6 mentions for MDxHealth and 3 mentions for Pulmonx. Pulmonx's average media sentiment score of 0.62 beat MDxHealth's score of 0.57 indicating that Pulmonx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulmonx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MDxHealth 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

MDxHealth (MDXH) Competitors

$0.41 -0.01 (-2.91%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$0.41 +0.00 (+0.73%)

As of 07/24/2026 07:21 PM Eastern

Compare

MDXH vs. ZEPP, PIII, OM, NYXH, and LUNG

Should you buy MDxHealth stock or one of its competitors? MarketBeat compares MDxHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MDxHealth include Zepp Health (ZEPP), P3 Health Partners (PIII), Outset Medical (OM), Nyxoah (NYXH), and Pulmonx (LUNG). These companies are all part of the "medical info sys" industry.

How does MDxHealth compare to Zepp Health?

Zepp Health (NYSE:ZEPP) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Zepp Health has a net margin of -14.70% compared to MDxHealth's net margin of -29.90%. MDxHealth's return on equity of 0.00% beat Zepp Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
MDxHealth	-29.90%	N/A	-22.51%

Zepp Health has a beta of 1.83, indicating that its share price is 83% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

Zepp Health presently has a consensus target price of $56.28, indicating a potential upside of 1,040.43%. MDxHealth has a consensus target price of $3.50, indicating a potential upside of 753.66%. Given Zepp Health's higher probable upside, equities analysts plainly believe Zepp Health is more favorable than MDxHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

MDxHealth has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$271.91M	0.27	-$40.07M	-$2.52	N/A
MDxHealth	$110.97M	0.18	-$33.52M	-$0.65	N/A

52.6% of Zepp Health shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 1.7% of MDxHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, MDxHealth had 6 more articles in the media than Zepp Health. MarketBeat recorded 6 mentions for MDxHealth and 0 mentions for Zepp Health. MDxHealth's average media sentiment score of 0.57 beat Zepp Health's score of 0.45 indicating that MDxHealth is being referred to more favorably in the news media.

Company	Overall Sentiment
Zepp Health	Neutral
MDxHealth	Positive

Summary

Zepp Health and MDxHealth tied by winning 8 of the 16 factors compared between the two stocks.

How does MDxHealth compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

P3 Health Partners currently has a consensus price target of $14.00, suggesting a potential upside of 45.53%. MDxHealth has a consensus price target of $3.50, suggesting a potential upside of 753.66%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts plainly believe MDxHealth is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

7.8% of P3 Health Partners shares are held by institutional investors. 10.9% of P3 Health Partners shares are held by company insiders. Comparatively, 1.7% of MDxHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

P3 Health Partners has a beta of 1.62, meaning that its stock price is 62% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

In the previous week, MDxHealth had 4 more articles in the media than P3 Health Partners. MarketBeat recorded 6 mentions for MDxHealth and 2 mentions for P3 Health Partners. P3 Health Partners' average media sentiment score of 0.63 beat MDxHealth's score of 0.57 indicating that P3 Health Partners is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MDxHealth	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

P3 Health Partners has a net margin of -8.57% compared to MDxHealth's net margin of -29.90%.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-8.57%	N/A	-19.99%
MDxHealth	-29.90%	N/A	-22.51%

MDxHealth has lower revenue, but higher earnings than P3 Health Partners. MDxHealth is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.47B	0.05	-$147.95M	-$38.60	N/A
MDxHealth	$110.97M	0.18	-$33.52M	-$0.65	N/A

Summary

P3 Health Partners beats MDxHealth on 8 of the 15 factors compared between the two stocks.

How does MDxHealth compare to Outset Medical?

Outset Medical (NASDAQ:OM) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability.

Outset Medical has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

MDxHealth has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$117.59M	0.64	-$81.65M	-$4.16	N/A
MDxHealth	$110.97M	0.18	-$33.52M	-$0.65	N/A

In the previous week, MDxHealth had 2 more articles in the media than Outset Medical. MarketBeat recorded 6 mentions for MDxHealth and 4 mentions for Outset Medical. Outset Medical's average media sentiment score of 1.34 beat MDxHealth's score of 0.57 indicating that Outset Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MDxHealth	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MDxHealth has a net margin of -29.90% compared to Outset Medical's net margin of -63.65%. MDxHealth's return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
MDxHealth	-29.90%	N/A	-22.51%

Outset Medical presently has a consensus target price of $10.00, indicating a potential upside of 147.52%. MDxHealth has a consensus target price of $3.50, indicating a potential upside of 753.66%. Given MDxHealth's higher possible upside, analysts clearly believe MDxHealth is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

MDxHealth beats Outset Medical on 8 of the 12 factors compared between the two stocks.

How does MDxHealth compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

MDxHealth has higher revenue and earnings than Nyxoah. MDxHealth is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$15.33M	3.54	-$101.92M	-$2.48	N/A
MDxHealth	$110.97M	0.18	-$33.52M	-$0.65	N/A

In the previous week, MDxHealth had 5 more articles in the media than Nyxoah. MarketBeat recorded 6 mentions for MDxHealth and 1 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.87 beat MDxHealth's score of 0.57 indicating that Nyxoah is being referred to more favorably in the media.

Company	Overall Sentiment
Nyxoah	Very Positive
MDxHealth	Positive

MDxHealth has a net margin of -29.90% compared to Nyxoah's net margin of -543.21%. MDxHealth's return on equity of 0.00% beat Nyxoah's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-543.21%	-163.73%	-80.24%
MDxHealth	-29.90%	N/A	-22.51%

Nyxoah has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market.

Nyxoah currently has a consensus price target of $5.96, suggesting a potential upside of 325.89%. MDxHealth has a consensus price target of $3.50, suggesting a potential upside of 753.66%. Given MDxHealth's stronger consensus rating and higher possible upside, analysts clearly believe MDxHealth is more favorable than Nyxoah.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

MDxHealth beats Nyxoah on 10 of the 14 factors compared between the two stocks.

How does MDxHealth compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and MDxHealth (NASDAQ:MDXH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

MDxHealth has higher revenue and earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$88.55M	0.56	-$54M	-$1.30	N/A
MDxHealth	$110.97M	0.18	-$33.52M	-$0.65	N/A

Pulmonx currently has a consensus price target of $5.58, suggesting a potential upside of 377.21%. MDxHealth has a consensus price target of $3.50, suggesting a potential upside of 753.66%. Given MDxHealth's higher possible upside, analysts clearly believe MDxHealth is more favorable than Pulmonx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
MDxHealth	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

MDxHealth has a net margin of -29.90% compared to Pulmonx's net margin of -60.09%. MDxHealth's return on equity of 0.00% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-60.09%	-92.94%	-39.80%
MDxHealth	-29.90%	N/A	-22.51%

Pulmonx has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, MDxHealth has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

91.0% of Pulmonx shares are owned by institutional investors. 7.5% of Pulmonx shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, MDxHealth had 3 more articles in the media than Pulmonx. MarketBeat recorded 6 mentions for MDxHealth and 3 mentions for Pulmonx. Pulmonx's average media sentiment score of 0.62 beat MDxHealth's score of 0.57 indicating that Pulmonx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulmonx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MDxHealth	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

MDxHealth beats Pulmonx on 10 of the 16 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDXH vs. The Competition

Export

Metric	MDxHealth	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$20.29M	$1.68B	$6.87B	$12.26B
Dividend Yield	N/A	N/A	2.67%	9.79%
P/E Ratio	-0.63	74.42	27.14	23.64
Price / Sales	0.18	62.75	517.06	88.99
Price / Cash	N/A	26.11	50.54	59.64
Price / Book	-1.71	4.98	10.28	6.07
Net Income	-$33.52M	-$54.76M	$3.60B	$331.99M
7 Day Performance	-3.03%	-6.95%	-1.27%	-0.63%
1 Month Performance	-9.81%	-2.60%	-0.37%	-2.00%
1 Year Performance	-83.53%	-11.12%	18.30%	13.62%

MDxHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDXH MDxHealth	2.918 of 5 stars	$0.41 -2.9%	$3.50 +753.7%	-83.2%	$20.29M	$110.97M	N/A	300	News Coverage Short Interest Increase
ZEPP Zepp Health	1.9384 of 5 stars	$5.52 +4.3%	$56.28 +919.6%	-56.7%	$77.66M	$271.91M	N/A	1,230
PIII P3 Health Partners	2.5072 of 5 stars	$10.07 -5.1%	$14.00 +39.0%	+32.1%	$76.87M	$1.46B	N/A	500	Gap Down
OM Outset Medical	3.5352 of 5 stars	$4.12 +1.5%	$10.00 +142.7%	-77.1%	$75.26M	$117.59M	N/A	520	News Coverage Positive News Gap Down
NYXH Nyxoah	3.3024 of 5 stars	$1.54 -1.3%	$5.96 +287.2%	-82.0%	$60.47M	$11.33M	N/A	110	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDXH) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MDxHealth (MDXH) Competitors

MDXH vs. ZEPP, PIII, OM, NYXH, and LUNG

How does MDxHealth compare to Zepp Health?

Summary

How does MDxHealth compare to P3 Health Partners?

Summary

How does MDxHealth compare to Outset Medical?

Summary

How does MDxHealth compare to Nyxoah?

Summary

How does MDxHealth compare to Pulmonx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MDxHealth (MDXH) Competitors

MDXH vs. ZEPP, PIII, OM, NYXH, and LUNG

How does MDxHealth compare to Zepp Health?

Is ZEPP or MDXH more profitable?

Which has more volatility & risk, ZEPP or MDXH?

Do analysts recommend ZEPP or MDXH?

Which has preferable earnings and valuation, ZEPP or MDXH?

Do institutionals and insiders have more ownership in ZEPP or MDXH?

Does the media favor ZEPP or MDXH?

Summary

How does MDxHealth compare to P3 Health Partners?

Do analysts prefer PIII or MDXH?

Do institutionals & insiders have more ownership in PIII or MDXH?

Which has more risk and volatility, PIII or MDXH?

Does the media refer more to PIII or MDXH?

Is PIII or MDXH more profitable?

Which has higher earnings & valuation, PIII or MDXH?

Summary

How does MDxHealth compare to Outset Medical?

Which has more volatility and risk, OM or MDXH?

Which has better earnings and valuation, OM or MDXH?

Does the media favor OM or MDXH?

Is OM or MDXH more profitable?

Do analysts rate OM or MDXH?

Summary

How does MDxHealth compare to Nyxoah?

Which has better valuation & earnings, NYXH or MDXH?

Does the media refer more to NYXH or MDXH?

Is NYXH or MDXH more profitable?

Which has more risk and volatility, NYXH or MDXH?

Do analysts rate NYXH or MDXH?

Summary

How does MDxHealth compare to Pulmonx?

Which has better valuation & earnings, LUNG or MDXH?

Do analysts rate LUNG or MDXH?

Is LUNG or MDXH more profitable?

Which has more risk and volatility, LUNG or MDXH?

Do insiders and institutionals hold more shares of LUNG or MDXH?

Does the media favor LUNG or MDXH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDXH vs. The Competition

MDxHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools